Anatara Lifesciences Ltd (AU:ANR) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Anatara Lifesciences Ltd successfully raised $274,500 through a Share Purchase Plan (SPP), complementing a recent $750,000 placement with institutional investors. The funds will support the company’s Phase II clinical study for its GaRP medication targeting irritable bowel syndrome and an anti-obesity project. This financial boost marks a significant step forward for Anatara’s innovative gastrointestinal and weight management solutions.
For further insights into AU:ANR stock, check out TipRanks’ Stock Analysis page.